UnitedHealth Group Receives “Buy” Rating from TheStreet (UNH)
UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating restated by equities researchers at TheStreet in a research report issued on Tuesday, Analyst Ratings Net reports.
The analysts wrote, “UnitedHealth Group (UNH) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.”
UnitedHealth Group (NYSE:UNH) opened at 69.85 on Tuesday. UnitedHealth Group has a 52-week low of $52.51 and a 52-week high of $77.33. The stock has a 50-day moving average of $73.27 and a 200-day moving average of $72.35. The company has a market cap of $70.828 billion and a price-to-earnings ratio of 12.68.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Wednesday, January 15th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.01. The company had revenue of $31.10 billion for the quarter, compared to the consensus estimate of $31.06 billion. During the same quarter in the previous year, the company posted $1.20 earnings per share. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. Analysts expect that UnitedHealth Group will post $5.60 EPS for the current fiscal year.
A number of other firms have also recently commented on UNH. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 22nd. Separately, analysts at Monness Crespi & Hardt downgraded shares of UnitedHealth Group from a “neutral” rating to a “sell” rating in a research note on Tuesday, January 21st. They now have a $59.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of UnitedHealth Group in a research note on Friday, January 17th. They now have a $76.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $78.72.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.